Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri P Mikhailidis

Showing results (391-400 of 675) with videos related to

Pageof 68
Sort By:
Current Pharmaceutical Design|December 7, 2010
Chronic hepatitis C, insulin resistance and vascular diseaseAndreja Trpkovic, Edith Stokic, Djordje Radak, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 12, 2005
Effect of antihypertensive treatment on plasma fibrinogen and serum HDL levels in patients with essential hypertensionJohn A Papadakis, Dimitri P Mikhailidis, George E Vrentzos, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 29, 2010
The role of polyphenols in cardiovascular diseaseMarta Michalska, Anna Gluba, Dimitri P Mikhailidis, et al.
Rheumatology International|April 15, 2010
Platelet function in rheumatoid arthritis: arthritic and cardiovascular implicationsArmen Yuri Gasparyan, Antonios Stavropoulos-Kalinoglou, Dimitri P Mikhailidis, et al.
Current Pharmaceutical Design|November 8, 2017
Effect of Metformin on Plasma Fibrinogen Concentrations: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsLuis E Simental-Mendia, Matteo Pirro, Stephen L Atkin, et al.
Archives of Medical Science : AMS|July 14, 2022
Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (<i>n</i> = 355,591) and randomized controlled trials (<i>n</i> = 165,988)Maciej Banach, Niloofar Shekoohi, Dimitri P Mikhailidis, et al.
Journal of Physiology and Biochemistry|July 24, 2010
Effects of L-canavanine and ozone on vascular reactivity in septicemic ratsMohamed A Haidara, Mohamed D Morsy, Hesham A Abdel-Razek, et al.
Metabolism: Clinical and Experimental|June 2, 2012
11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?Panagiotis Anagnostis, Niki Katsiki, Fotini Adamidou, et al.
Current Pharmaceutical Design|January 5, 2013
PCSK9 inhibition - a novel mechanism to treat lipid disorders?Maciej Banach, Manfredi Rizzo, Milan Obradovic, et al.
Angiology|May 29, 2008
Do different vascular risk factors affect all arteries equally?Kosmas I Paraskevas, Nikolaos Bessias, Theofanis T Papas, et al.
Pageof 68

Showing results (391-400 of 675) with videos related to

Sort By:
Pageof 68
Current Pharmaceutical Design|December 7, 2010
Chronic hepatitis C, insulin resistance and vascular diseaseAndreja Trpkovic, Edith Stokic, Djordje Radak, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 12, 2005
Effect of antihypertensive treatment on plasma fibrinogen and serum HDL levels in patients with essential hypertensionJohn A Papadakis, Dimitri P Mikhailidis, George E Vrentzos, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 29, 2010
The role of polyphenols in cardiovascular diseaseMarta Michalska, Anna Gluba, Dimitri P Mikhailidis, et al.
Rheumatology International|April 15, 2010
Platelet function in rheumatoid arthritis: arthritic and cardiovascular implicationsArmen Yuri Gasparyan, Antonios Stavropoulos-Kalinoglou, Dimitri P Mikhailidis, et al.
Current Pharmaceutical Design|November 8, 2017
Effect of Metformin on Plasma Fibrinogen Concentrations: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsLuis E Simental-Mendia, Matteo Pirro, Stephen L Atkin, et al.
Archives of Medical Science : AMS|July 14, 2022
Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (<i>n</i> = 355,591) and randomized controlled trials (<i>n</i> = 165,988)Maciej Banach, Niloofar Shekoohi, Dimitri P Mikhailidis, et al.
Journal of Physiology and Biochemistry|July 24, 2010
Effects of L-canavanine and ozone on vascular reactivity in septicemic ratsMohamed A Haidara, Mohamed D Morsy, Hesham A Abdel-Razek, et al.
Metabolism: Clinical and Experimental|June 2, 2012
11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?Panagiotis Anagnostis, Niki Katsiki, Fotini Adamidou, et al.
Current Pharmaceutical Design|January 5, 2013
PCSK9 inhibition - a novel mechanism to treat lipid disorders?Maciej Banach, Manfredi Rizzo, Milan Obradovic, et al.
Angiology|May 29, 2008
Do different vascular risk factors affect all arteries equally?Kosmas I Paraskevas, Nikolaos Bessias, Theofanis T Papas, et al.
Pageof 68